US Stock MarketDetailed Quotes

Artelo Biosciences (ARTL)

Watchlist
  • 4.440
  • -0.420-8.64%
Close Apr 17 16:00 ET
  • 4.420
  • -0.020-0.45%
Post 20:01 ET
4.17MMarket Cap-0.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Artelo Biosciences (ARTL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.82%11.4M
-26.92%2.79M
158.49%3.09M
25.40%3.15M
-8.11%2.38M
1.79%10.11M
17.65%3.81M
-54.28%1.2M
40.81%2.51M
12.96%2.59M
Selling and administrative expenses
45.35%5.98M
41.69%1.89M
108.51%1.81M
54.66%1.28M
-8.04%995K
-2.81%4.12M
19.71%1.34M
-15.45%870K
-19.86%827K
2.37%1.08M
-General and administrative expense
45.35%5.98M
41.69%1.89M
108.51%1.81M
54.66%1.28M
-8.04%995K
-2.81%4.12M
19.71%1.34M
-15.45%870K
-19.86%827K
2.37%1.08M
Research and development costs
-9.51%5.42M
-63.93%893K
292.31%1.28M
11.04%1.87M
-8.16%1.38M
5.21%5.99M
16.57%2.48M
-79.50%325K
124.07%1.69M
22.02%1.51M
Operating profit
-12.82%-11.4M
26.92%-2.79M
-158.49%-3.09M
-25.40%-3.15M
8.11%-2.38M
-1.79%-10.11M
-17.65%-3.81M
54.28%-1.2M
-40.81%-2.51M
-12.96%-2.59M
Net non-operating interest income expense
-277K
-107K
-106K
-71K
7K
0
0
0
0
0
Non-operating interest income
----
----
--5K
--1K
--7K
----
----
--0
--0
--0
Non-operating interest expense
--277K
--94K
--111K
--72K
----
--0
--0
--0
--0
----
Other net income (expense)
-524.82%-1.2M
-3,844.12%-1.27M
19.05%75K
-56.01%282K
-79.64%34K
-61.82%63K
-57.30%79K
-14.52%106K
Gain on sale of security
-114.18%-40K
----
----
----
----
-56.01%282K
-79.64%34K
-61.82%63K
-57.30%79K
-14.52%106K
Special income (charges)
---1.16M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--1.16M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
--75K
----
----
----
----
----
----
----
Income before tax
-31.07%-12.88M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-5.78%-9.83M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-31.07%-12.88M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-5.78%-9.83M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
Net income continuous Operations
-31.07%-12.88M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-5.78%-9.83M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
Minority interest income
Net income attributable to the parent company
-31.07%-12.88M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-5.78%-9.83M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.07%-12.88M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-5.78%-9.83M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
Basic earnings per share
31.58%-37.56
70.61%-6.1901
-89.05%-11.91
-24.12%-16.83
7.69%-12.96
2.87%-54.9
-18.18%-21.06
57.83%-6.3
-34.52%-13.56
-2.63%-14.04
Diluted earnings per share
31.58%-37.56
70.61%-6.1901
-89.05%-11.91
-24.12%-16.83
7.69%-12.96
2.87%-54.9
-18.18%-21.06
57.83%-6.3
-34.52%-13.56
-2.63%-14.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.82%11.4M-26.92%2.79M158.49%3.09M25.40%3.15M-8.11%2.38M1.79%10.11M17.65%3.81M-54.28%1.2M40.81%2.51M12.96%2.59M
Selling and administrative expenses 45.35%5.98M41.69%1.89M108.51%1.81M54.66%1.28M-8.04%995K-2.81%4.12M19.71%1.34M-15.45%870K-19.86%827K2.37%1.08M
-General and administrative expense 45.35%5.98M41.69%1.89M108.51%1.81M54.66%1.28M-8.04%995K-2.81%4.12M19.71%1.34M-15.45%870K-19.86%827K2.37%1.08M
Research and development costs -9.51%5.42M-63.93%893K292.31%1.28M11.04%1.87M-8.16%1.38M5.21%5.99M16.57%2.48M-79.50%325K124.07%1.69M22.02%1.51M
Operating profit -12.82%-11.4M26.92%-2.79M-158.49%-3.09M-25.40%-3.15M8.11%-2.38M-1.79%-10.11M-17.65%-3.81M54.28%-1.2M-40.81%-2.51M-12.96%-2.59M
Net non-operating interest income expense -277K-107K-106K-71K7K00000
Non-operating interest income ----------5K--1K--7K----------0--0--0
Non-operating interest expense --277K--94K--111K--72K------0--0--0--0----
Other net income (expense) -524.82%-1.2M-3,844.12%-1.27M19.05%75K-56.01%282K-79.64%34K-61.82%63K-57.30%79K-14.52%106K
Gain on sale of security -114.18%-40K-----------------56.01%282K-79.64%34K-61.82%63K-57.30%79K-14.52%106K
Special income (charges) ---1.16M------------------0----------------
-Less:Other special charges --1.16M------------------------------------
Other non- operating income (expenses) ----------75K----------------------------
Income before tax -31.07%-12.88M-10.27%-4.17M-175.62%-3.12M-32.39%-3.22M4.47%-2.37M-5.78%-9.83M-22.94%-3.78M53.78%-1.13M-52.16%-2.43M-14.53%-2.48M
Income tax 0000000000
Net income -31.07%-12.88M-10.27%-4.17M-175.62%-3.12M-32.39%-3.22M4.47%-2.37M-5.78%-9.83M-22.94%-3.78M53.78%-1.13M-52.16%-2.43M-14.53%-2.48M
Net income continuous Operations -31.07%-12.88M-10.27%-4.17M-175.62%-3.12M-32.39%-3.22M4.47%-2.37M-5.78%-9.83M-22.94%-3.78M53.78%-1.13M-52.16%-2.43M-14.53%-2.48M
Minority interest income
Net income attributable to the parent company -31.07%-12.88M-10.27%-4.17M-175.62%-3.12M-32.39%-3.22M4.47%-2.37M-5.78%-9.83M-22.94%-3.78M53.78%-1.13M-52.16%-2.43M-14.53%-2.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.07%-12.88M-10.27%-4.17M-175.62%-3.12M-32.39%-3.22M4.47%-2.37M-5.78%-9.83M-22.94%-3.78M53.78%-1.13M-52.16%-2.43M-14.53%-2.48M
Basic earnings per share 31.58%-37.5670.61%-6.1901-89.05%-11.91-24.12%-16.837.69%-12.962.87%-54.9-18.18%-21.0657.83%-6.3-34.52%-13.56-2.63%-14.04
Diluted earnings per share 31.58%-37.5670.61%-6.1901-89.05%-11.91-24.12%-16.837.69%-12.962.87%-54.9-18.18%-21.0657.83%-6.3-34.52%-13.56-2.63%-14.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -